US pharmacy pricing
Neulasta Prices at US Pharmacies
Lowest price found · US pharmacies
$6,278.80/fill
for Neulasta, across the pharmacies in our data
US pharmacy prices — 0.6ml of 6mg/0.6ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $6,278.80Lowest | $6,281.80 | $1,535.63 |
 Harris Teeter Pharmacy | $6,278.80Lowest | $6,281.80 | $1,535.63 |
 Walgreens | $6,588.61 | $6,591.61 | $1,535.63 |
 Publix | $6,631.37 | $6,631.37 | $1,535.63 |
 Costco | $6,779.40 | $6,782.40 | $1,535.63 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Neulasta.
Frequently asked questions
Is Neulasta (Neulasta) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Neulasta is around $6,278.80. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Neulasta available?
Generic and brand-name pricing for Neulasta is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
Is a generic version of Neulasta available?
There is no true generic (biosimilar) for pegfilgrastim, the active ingredient in Neulasta. However, pegfilgrastim is also marketed under a different brand name, Udenyca, manufactured by Coherus BioSciences. Like Neulasta, Udenyca is a branded biologic medication and is also associated with a high cost.
What is Neulasta and how is it used?
Neulasta is an FDA-approved injectable medication known as a colony-stimulating factor. Its active ingredient, pegfilgrastim, is a manufactured protein that stimulates the bone marrow to produce neutrophils, a type of white blood cell essential for fighting infection. It is prescribed for patients receiving cancer treatments like chemotherapy or radiation, which can suppress the immune system and increase infection risk. Administration occurs in a clinical setting—either as a direct injection or via an on-body injector applied before the patient leaves the facility. This injector automatically delivers the dose 27 hours after placement. Treatment is typically given once per chemotherapy cycle.
What side effects are associated with Neulasta?
Bone pain and pain in the extremities are among the most frequently reported side effects of Neulasta. Other common reactions can involve the injection site, such as redness, swelling, or bruising. More serious, though less common, risks include spleen rupture, acute respiratory distress syndrome (ARDS), kidney injury, and severe allergic reactions (anaphylaxis). Seek immediate medical care if you experience signs of a serious reaction, like difficulty breathing or a severe rash. Always consult your doctor or healthcare provider for a complete list of potential side effects, warnings, and precautions before starting this medication.